Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2019
The primary objective of this study is to demonstrate equivalence of the pharmacokinetic (PK) profile of MSB11022 administered by either an auto-injector (AI) or a pre-filled syringe (PFS) as single subcutaneous (s.c.) injection of 40 mg.
Epistemonikos ID: 45a60651e607edf52f4b4fdb29629673286e844e
First added on: Feb 15, 2022